Draft Evidence Report
New England CEPAC

PDF cover

This is not the most recent version of this material.
For an updated version, please see the relevant topic page.

Endometriosis: Draft Evidence Report

ICER’s Draft Evidence Report on elagolix for endometriosis, open to public comment until May 31, 2018 at 5pm ET. For more information on submitting a public comment, please visit our stakeholder engagement page.


View All Materials on this Topic or Go Back to View More Materials